Jan 14, 2009
By:
George Koroneos, Online Content & News Editor
One week after submitting data to get Gardasil approved for men, Merck gets a total response letter from FDA requesting additional data before it makes a decision on authorizing the drug for older women.
|
Jan 14, 2009
By:
George Koroneos, Online Content & News Editor
Sales reps aren't the only ones heading for the unemployment line - Pfizer is eliminating researcher positions as fewer drugs are making it to development. But could streamlining the crux of drug R&D cause more harm than good?
|
Jan 7, 2009
By:
George Koroneos, Online Content & News Editor
One week into the new year, and word is trickling out that some large advertising firms are gearing up for heavy cuts. First out the gate is WPP, which is expected to be cutting thousands of jobs.
|
Jan 7, 2009
By:
George Koroneos, Online Content & News Editor
With the departure and retirement of two-thirds of Donahoe Purohit Miller, the middle child has rebranded itself Purohit Navigation and is going after the pharma market as a one-stop-shop for all its branding needs.
|
Jan 7, 2009
By:
George Koroneos, Online Content & News Editor
Merck isn't bragging about the positive data it received regarding the use of its landmark HPV vaccine in men. But the pharma giant also isn't wasting time submitting the info to FDA. Pharm Exec talked to the lead investigator behind the trials to find out why this could be another milestone for Merck.
|
Dec 17, 2008
By:
George Koroneos, Online Content & News Editor
Consumer pharma marketers are going to have to be a little more careful when using celebrity spokespeople or actors playing physicians. PhRMA has updated its rules and the consensus is clear - if you are paying for promotion, it must be noted in the ad.
|
Dec 17, 2008
By:
George Koroneos, Online Content & News Editor
Forget putting a cap on how much a gift to doctors should cost, the state of Massachusetts is considering outlawing everything from pens to meals - and don't even think about handing out free tickets to next week's Red Sox game.
|
Dec 17, 2008
By:
George Koroneos, Online Content & News Editor
New study shows that physicians aren't as opposed to sales rep visits as some might think. However, a growing number of docs are becoming fans of rep meetings in conjunction with some form of electronic detailing.
|
Dec 11, 2008
By:
George Koroneos, Online Content & News Editor
Pharm Exec talks with James Christian, head of security at Novartis, to learn more about what the company is doing to protect its supply chain and stop counterfeiters
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
